Pacific Biosciences of California, Inc. (NASDAQ:PACB)

CAPS Rating: 3 out of 5

Results 1 - 20 of 28 : 1 2 Next »

Recs

0
Member Avatar nobst (< 20) Submitted: 1/26/2013 8:00:27 AM : Outperform Start Price: $2.60 PACB Score: -18.50

Qualitatively different to DNA sequencing

Recs

0
Member Avatar panesh (22.37) Submitted: 1/24/2013 11:47:01 AM : Outperform Start Price: $2.49 PACB Score: -14.13

This stock has been much higher than this and will return to 2 bagger status

Recs

0
Member Avatar gtechie (28.09) Submitted: 1/15/2013 2:58:49 PM : Outperform Start Price: $2.79 PACB Score: -26.86

Has it finally turned the corner? It's been up pretty big lately, and I'm making a CAPS bet that it'll continue.

Recs

0
Member Avatar wossamattau (< 20) Submitted: 9/25/2012 1:42:25 AM : Outperform Start Price: $3.18 PACB Score: -72.30

Please, for the love of God! Someone buy this boat anchor out! Hammered in RL on this Gem.
Amazing technology, could be a game changer. Could. Im in too deep to give up now. Green thumb all the way to the bottom of the ocen! Strange...Looks like an iceberg up ahead!

Recs

0
Member Avatar mattyabe (44.33) Submitted: 6/23/2012 9:17:32 PM : Outperform Start Price: $2.00 PACB Score: -5.42

Both PACB and GNOM are beat up right now, and it's only a matter of time before one of them takes off. It may be smart to buy both instead of guessing which one

Recs

3
Member Avatar Momentum21 (98.13) Submitted: 5/9/2012 10:58:06 AM : Outperform Start Price: $2.46 PACB Score: -25.01

doubling my position in real life, I am pot committed to this sequencer now... : ) started buying at 10 and change...doubled at $2.46

Recs

0
Member Avatar mwlove (28.78) Submitted: 4/21/2012 4:35:28 PM : Outperform Start Price: $2.74 PACB Score: -33.94

Cool products, but a tepid market for them at the moment. I think they can stay in business until their prospects improve. Or, they are take-over target. A frankly speculative play with high risks, but potentially multi-bagger rewards

Recs

1
Member Avatar DebbyDo101 (31.07) Submitted: 3/25/2012 2:55:24 AM : Outperform Start Price: $3.99 PACB Score: -58.04

This is the risky one, but they will either pull the rabbit out of the hat or not. They have a machine that does gene resequencing for about a thousand dollars.
A stock at the price I would be willing to invest in because I believe in the product and will put some money behind it. Just not a lot of money. All I can lose is 3.93 a share.

Recs

0
Member Avatar CATomla (< 20) Submitted: 2/7/2012 12:57:52 PM : Outperform Start Price: $4.87 PACB Score: -74.16

No place to go but up.

Recs

0
Member Avatar badgervb (< 20) Submitted: 10/3/2011 11:45:08 PM : Underperform Start Price: $2.97 PACB Score: +72.59

investigation...and i own some. i am the kiss of death!

Recs

3
Member Avatar NeuroNerd (< 20) Submitted: 9/30/2011 1:24:34 PM : Outperform Start Price: $3.41 PACB Score: -74.60

The floor where I work just received one of their next-gen sequencers. It is quite possibly the coolest thing I have ever seen. I think it is fair to say that adoption will be slower than management's original optimistic projections because of the price tag; however, my suspicion is that the razor-and-blade model will allow them to eventually become profitable as specialized centers like ours adopt them. They really do have capabilities that leave the competition in the dust for certain applications.

Recs

0
Member Avatar tmurphyphd (20.01) Submitted: 9/7/2011 1:53:09 PM : Outperform Start Price: $6.12 PACB Score: -99.88

Smart product in emerging industry

Recs

0
Member Avatar Keekers44 (85.09) Submitted: 9/3/2011 12:39:41 PM : Outperform Start Price: $5.79 PACB Score: -104.14

This highly volitile stock is definately a speculative play for a while. Shares droped 30% after some bad news regarding gross margins. I believe that drop was a bit drastic.

Recs

0
Member Avatar bodie17 (< 20) Submitted: 8/6/2011 6:53:33 AM : Outperform Start Price: $6.45 PACB Score: -105.27

Don't you want a genetic analysis too?

Recs

0
Member Avatar Blackarrow1969 (26.77) Submitted: 8/5/2011 6:51:37 PM : Outperform Start Price: $6.45 PACB Score: -105.27

They had a great quarterly report but got creamed due to a JPM downgrade. It's a long-term spec stock with great potential.

Recs

0
Member Avatar johnnymack91362 (75.89) Submitted: 6/30/2011 1:47:50 PM : Outperform Start Price: $11.63 PACB Score: -105.86

gamble time

Recs

0
Member Avatar mtnv110960 (52.97) Submitted: 6/24/2011 7:39:58 PM : Outperform Start Price: $11.46 PACB Score: -107.49

Mark this date down. Who buys 1.5 million shares after hours? Something is going on.............

Recs

0
Member Avatar latinoeconomist (28.19) Submitted: 6/23/2011 4:34:32 AM : Outperform Start Price: $10.83 PACB Score: -108.94

Is gearing up for explosive growth.

Recs

0
Member Avatar polterziets (< 20) Submitted: 6/4/2011 5:03:54 PM : Outperform Start Price: $11.54 PACB Score: -107.36

i like where their technology is going

Recs

0
Member Avatar simsimmarvin38 (< 20) Submitted: 5/29/2011 3:42:29 AM : Outperform Start Price: $12.20 PACB Score: -104.03

Clearly the most powerful technology with a large void to fill in the sequencing space. Granted it will have a slow start as centers have to phase out current technology over time but once momentum picks up this run will be hard to stop.

Results 1 - 20 of 28 : 1 2 Next »

Featured Broker Partners


Advertisement